InvestorsHub Logo

BBalllegend

12/13/23 1:21 PM

#192275 RE: DRHUMI #192274

this is ENZC's MAB?

docsetc

12/13/23 1:25 PM

#192276 RE: DRHUMI #192274

Nice! Thanks. It sure will be a shame if these trials move to phase 2, and Regeneron is not using ENZC for their mABs production, before ENZC even gets to the starting door.

One can only hope that the Euro trials they claimed can move to Phase III quickly in Europe, are still on the schedule.

falon

12/14/23 1:14 PM

#192350 RE: DRHUMI #192274

The trial is being done in Belgium at a University Research Hospital connected to a University of 50,000 students according to link you posted.

Belgium is in 2nd place in Europe, in terms of number of clinical trials per inhabitant.

https://pharma.be/sites/default/files/2021-09/brochure_clinical_trials.pdf